Kurzbeschreibung
appamedix develops mobile applications for the health sector using a design thinking approach.
Entwicklung von medizinische Apps
appamedix develops mobile applications for the health sector using a design thinking approach. The user-friendly apps designed by our interdisciplinary team reflect users’ needs, contributing to our apps’ high acceptability among patients—especially the elderly. In February 2018, appamedix won a tender for AMD e.V., a German patient network, and developed an app for the indication age-related macular degeneration (AMD). In 2020 and 2021, Appamedix developed a third app in the field of ophthalmology. An app for the indication glaucoma with the name glaucare, for the company of the same name: the glaucare GmbH. Johannes Vegt is part of the glaucare team.